Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin

被引:78
作者
Sader, Helio S.
Fritsche, Thomas R.
Jones, Ronald N.
机构
[1] JMI Labs, Beaver Creek Ctr 345, N Liberty, IA 52317 USA
[2] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil
[3] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
D O I
10.1128/AAC.01491-05
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 207 Staphylococcus aureus strains, including 105 well-characterized strains with decreased susceptibility to vancomycin (17 vancomycin-intermediate S. aureus [VISA] and 88 heteroresistant VISA [hVISA] strains) and 102 wild-type methicillin-resistant S. aureus (MRSA-WT) strains were tested by reference/standardized broth microdilution and disk diffusion methods, as well as by Etest (AB BIODISK, Solna, Sweden), against daptomycin and vancomycin. The lowest concentration of antimicrobial agent that killed >= 99.9% of the initial inoculum was defined as the minimum bactericidal concentration (MBC) endpoint, and time-kill curves were performed in selected strains to further evaluate bactericidal activity. All MRSA-WT and hVISA strains were inhibited by <= 1 g/ml of daptomycin, while the VISA strains showed slightly higher daptomycin MICs (range, 0.5 to 4 mu g/ml). All daptomycin MBC results were at the MIC or twofold higher. In contrast, 14.7% of MRSA-WT, 69.3% of hVISA, and all VISA strains showed a vancomycin MBC/MIC ratio of :32 or an MBC of 16 mu g/ml (tolerant). The correlation coefficients between broth microdilution and disk diffusion method results were low for daptomycin (0.07) and vancomycin (0.11). Eight (3.8%) strains (all hVISA or VISA) were "nonsusceptible" to daptomycin by broth microdilution methods but susceptible by the disk diffusion method. For vancomycin, 35 (16.9%) strains were nonsusceptible by broth microdilution methods but susceptible by disk diffusion methods. In conclusion, daptomycin was highly bactericidal against S. aureus strains, and its bactericidal activity was not affected by decreased susceptibility to vancomycin. In contrast, many (one in seven) contemporary MRSA-WT, the majority of hVISA, and all VISA strains showed vancomycin MBC/MIC ratios consistent with tolerance, a predictor of poor clinical response. Disk diffusion tests generally failed to detect strains categorized as nonsusceptible to daptomycin or vancomycin by the reference broth microdilution method or Etest, and reassessment of breakpoints should be immediately attempted for MIC methods suggested as the test of choice.
引用
收藏
页码:2330 / 2336
页数:7
相关论文
共 29 条
[1]   Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model:: MICs do not predict in vivo efficacy [J].
Asseray, N ;
Jacqueline, C ;
Le Mabecque, V ;
Batard, E ;
Bugnon, D ;
Potel, G ;
Caillon, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :857-859
[2]  
BARRY AL, 1999, METHODS DETERMINING, V19
[3]   COMPARATIVE EFFICACY OF DAPTOMYCIN, VANCOMYCIN, AND CLOXACILLIN FOR THE TREATMENT OF STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN RATS AND ROLE OF TEST CONDITIONS IN THIS DETERMINATION [J].
CANTONI, L ;
GLAUSER, MP ;
BILLE, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) :2348-2353
[4]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P322
[5]   Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations [J].
Cha, R ;
Brown, WJ ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) :3960-3963
[6]   Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations [J].
Cha, R ;
Rybak, MJ .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 47 (03) :539-546
[7]  
*CLIN LAB STAND I, 2006, M100S16 CLSI
[8]   Staphylococcus aureus with reduced susceptibility to vancomycin [J].
Cosgrove, SE ;
Carroll, KC ;
Perl, TM .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) :539-545
[9]   SERIOUS STAPHYLOCOCCAL INFECTIONS WITH STRAINS TOLERANT TO BACTERICIDAL ANTIBIOTICS [J].
DENNY, AE ;
PETERSON, LR ;
GERDING, DN ;
HALL, WH .
ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (09) :1026-1031
[10]   A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections [J].
Domenech, A ;
Ribes, S ;
Cabellos, C ;
Domínguez, MA ;
Montero, A ;
Liñares, J ;
Ariza, J ;
Gudiol, F .
MICROBIAL DRUG RESISTANCE, 2004, 10 (04) :346-353